CLDI icon

Calidi Biotherapeutics

40 hedge funds and large institutions have $202M invested in Calidi Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$599K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$9.89M
2 +$9.85M
3 +$9.79M
4
Millennium Management
Millennium Management
New York
+$4.89M
5
Nomura Holdings
Nomura Holdings
Japan
+$1.83M

Top Sellers

1 -$10.1M
2 -$440K
3 -$56.5K
4
AA
AQR Arbitrage
Connecticut
-$14.2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$19.6M
2
$19.6M
3
$19.1M
4
$14.8M
5
$11.9M
6
$11.6M
7
$11.5M
8
$10.5M
9
$9.89M
10
$9.79M
11
$8.11M
12
$7.19M
13
$6.15M
14
$5.53M
15
$4.95M
16
$4.89M
17
$3.96M
18
$3.23M
19
$2.97M
20
$2.33M
21
$1.83M
22
$1.72M
23
$1.72M
24
$1.69M
25
$1.26M